Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Master Style PCLBKK:MASTER +3.85%56 EBITDA Margin % is 26.91% as of Mar. 2026, which is 14% below its 10-year median of 31.24. GuruFocus rates BKK:MASTER with a GF Score™ of 56/100 and a GF Value™ of ฿41.52 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Master Style PCL ranks better than 82.58% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Master Style PCL's EBITDA for the
three
months ended in Mar. 2026 was ฿117 Mil. Master Style PCL's Revenue for the
three
months ended in Mar. 2026 was ฿436 Mil. Therefore, Master Style PCL's EBITDA margin for the quarter that ended in Mar. 2026 was 26.91%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Master Style PCL EBITDA Margin % Related Terms
Master Style PCL EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Master Style PCL's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:MASTER vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Master Style PCL's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Master Style PCL EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Master Style PCL's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Master Style PCL's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Master Style PCL (BKK:MASTER) has a EBITDA Margin % of 26.91% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Master Style PCL and its competitors. This is 14% below median its historical median of 31.24. Over the past decade, Master Style PCL's EBITDA Margin % has ranged from 23.04 to 36.75. According to the industry distribution chart, Master Style PCL ranks #116 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 17.4%.
Is Master Style PCL's EBITDA Margin % too high?
Master Style PCL's current EBITDA Margin % of 26.91% is 14% below median its 10-year median of 31.24. Over the past 10 years, this metric has ranged from a low of 23.04 to a high of 36.75. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Master Style PCL's value of 26.91% is 162.9% above this industry median. Based on the distribution chart, Master Style PCL ranks #116 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Master Style PCL has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Master Style PCL's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Master Style PCL ranks #116 out of 666 companies for EBITDA Margin %. This places Master Style PCL in the top 17% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Master Style PCL's value of 26.91% is 162.9% above this benchmark. Historically, Master Style PCL's own EBITDA Margin % has ranged from 23.04 to 36.75 over the past decade. While the company's 10-year median is 31.24 vs. the industry median of 10.24, Master Style PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Master Style PCL's current EBITDA Margin % of 26.91% is 162.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Master Style PCL and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Master Style PCL's current EBITDA Margin % is 26.91%, which is 14% below median its own 10-year median of 31.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Master Style PCL stock overvalued right now?
Based on GuruFocus' analysis, Master Style PCL (BKK:MASTER) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿41.52, compared to a current price of ฿9.45 — trading 77.2% below its estimated fair value. The current EBITDA Margin % is 26.91%, which is 14% below median its 10-year median of 31.24 and 162.9% above the Healthcare Providers & Services industry median of 10.24. Master Style PCL's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Master Style PCL (BKK:MASTER), the current EBITDA Margin % is 26.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Master Style PCL (BKK:MASTER) Overvalued in 2026?
Based on GuruFocus' analysis, Master Style PCL stock appears to be undervalued.
The current stock price of ฿9.45 is trading 77.2% below its estimated GF Value™ of ฿41.52.
GuruFocus considers Master Style PCL to be Significantly Undervalued.
Key valuation signals for BKK:MASTER:
EBITDA Margin %: 26.91% (14% below median its 10-year median of 31.24)
GF Value™: ฿41.52 vs. price of ฿9.45 (77.2% below fair value)
Industry Position: 162.9% above the Healthcare Providers & Services median (#116 of 666)
No single metric tells the full story. See the BKK:MASTER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Master Style PCL is principally engaged in a cosmetic surgery hospital under the name of Masterpiece Hospital. It is a skincare and cosmetic surgery clinic. The company's services include: eye surgery, Nose surgery, Facial surgery, Hair transplant Liposuction and others. The company has two principal segments; Hospital business, which generates the majority of the revenue, and the trading of cosmetic products.
56GF Score
Get the complete analysis for BKK:MASTER
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MASTER has been successfully added to your 
